Michael Ball, MD
Interventional Cardiology · Indianapolis, INNPI 1396719761
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $59,395 of the $76,287 with a category attached, or 77.9%. Johnson & Johnson accounts for 75.8% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2019 at $28,171 and has fallen 93.7% since, to $1,762 in 2025. Among interventional cardiology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 311 payments — averaging $245.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$58K
- AstraZeneca$8K
- Medtronic$4K
- Abbott$1K
- Shockwave Medical, Inc$737
- E.r. Squibb & Sons, L.L.C.$661
- plus $4K from 23 others
Across 11 payments — averaging $5642.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$59K
- Medtronic$3K
What the payments were for
- Consulting fees$3000%
- Speaking & faculty fees$59,39578%
- Travel & lodging$5,1867%
- Food & beverage$11,40115%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 84 | $57,798 |
| AstraZeneca | 26 | $7,851 |
| Medtronic(2 entities) | 33 | $4,357 |
| Abbott | 10 | $1,225 |
| Shockwave Medical, Inc | 5 | $737 |
| E.r. Squibb & Sons, L.L.C. | 38 | $661 |
| Boston Scientific | 11 | $579 |
| Biotronik Inc. | 6 | $494 |
| Novartis | 21 | $396 |
| Pfizer | 21 | $305 |
| Abiomed | 3 | $280 |
| Philips North America LLC | 2 | $217 |
| Amgen | 11 | $212 |
| Asahi Intecc USA, Inc. | 1 | $200 |
| Edwards Lifesciences | 2 | $181 |
| Boehringer Ingelheim | 11 | $177 |
| Livanova USA, Inc. | 1 | $143 |
| Esperion Therapeutics, Inc. | 7 | $99 |
| Alnylam Pharmaceuticals Inc. | 3 | $80 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $66 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $46 |
| Lexicon Pharmaceuticals, Inc. | 2 | $39 |
| Amarin Pharma, Inc. | 2 | $37 |
| Novo Nordisk | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Mannkind Corporation | 1 | $15 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$56,158
- BRILINTA$7,434
- Resolute$3,036
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$737
- Orsiro Mission$469
- DRAGONFLY OPSTAR$332
- PK Papyrus$241
- ONYX FRONTIER$203
- Asahi Coronary Wires$200
- Diamondback Coronary$194
- XIENCE V$162
- GENERAL - THERAPIES$146
- Xience Sierra Coronary Stent$144
- ProtekDuo$143
- WATCHMAN Access System$130
- XIENCE SIERRA$129
- AVVIGO Guidance System$128
- IGT_D Systems$122
- BMW guide wires$121
- Mitra Clip system$120
How this compares
$76,287 in reported general payments places this provider in the 95th percentile of 170 interventional cardiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 477 | $613,478 |
| EliquisApixaban | 374 | $480,353 |
| EntrestoSacubitril/Valsartan | 193 | $267,931 |
| FarxigaDapagliflozin Propanediol | 76 | $99,159 |
| Repatha SureclickEvolocumab | 98 | $98,034 |
| JardianceEmpagliflozin | 59 | $85,577 |
| BrilintaTicagrelor | 59 | $56,764 |
| Nebivolol Hcl | 526 | $31,861 |
| Praluent PenAlirocumab | 45 | $31,610 |
| Metoprolol Succinate | 736 | $9,859 |
| ClopidogrelClopidogrel Bisulfate | 692 | $8,181 |
| Rosuvastatin Calcium | 702 | $8,022 |
| Valsartan | 263 | $6,839 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 188 | $6,540 |
| Atorvastatin Calcium | 576 | $4,884 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $57,798 | $613,478477 claims |
| PfizerEliquis | $305 | $480,353374 claims |
| NovartisEntresto | $396 | $267,931193 claims |
| AstraZenecaFarxiga, Brilinta | $7,851 | $155,923135 claims |
| Boehringer IngelheimJardiance | $177 | $85,57759 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 170 interventional cardiology providers in Indiana.
Other interventional cardiology in Indianapolis
- James HermillerIndianapolis$307K
- Woodrow CoreyIndianapolis$262K
- Anjan SinhaIndianapolis$54K
- Nitesh GadeelaIndianapolis$48K
- George RevtyakIndianapolis$45K
- Scott SharpIndianapolis$41K
- Amrish MalhiIndianapolis$37K
- Jeffrey BreallIndianapolis$21K
- Sandeep DubeIndianapolis$21K
- Kevin BallIndianapolis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.